Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Kerry G Bemis"'
Autor:
Sergio Kaiser, Lisa A Foltz, Carolyn A George, Sandra C Kirkwood, Kerry G Bemis, Xi Lin, Lawrence M Gelbert, Laura K Nisenbaum
Publikováno v:
Neurobiology of Disease, Vol 16, Iss 1, Pp 220-235 (2004)
Acute phencyclidine induces schizophrenia-like symptoms in healthy humans and psychotic episodes in schizophrenics. Although phencyclidine is known as a N-methyl d-aspartate receptor antagonist (NMDA-R), the molecular events underlying the behavioral
Externí odkaz:
https://doaj.org/article/24a6183442a04197a019d3b92ebf2712
Autor:
Sharon K Huang, Marlene M Darfler, Michael B Nicholl, Jinsam You, Kerry G Bemis, Tony J Tegeler, Mu Wang, Jean-Pierre Wery, Kelly K Chong, Linhda Nguyen, Richard A Scolyer, Dave S B Hoon
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4430 (2009)
Melanoma metastasis status is highly associated with the overall survival of patients; yet, little is known about proteomic changes during melanoma tumor progression. To better understand the changes in protein expression involved in melanoma progres
Externí odkaz:
https://doaj.org/article/fe32f607643c41379704caeebf0e7114
Autor:
Mu Wang, Lauren N. Bell, Naga Chalasani, Raj Vuppalanchi, Kerry G. Bemis, Janice L. Theodorakis, Romil Saxena
Publikováno v:
Hepatology. 51:111-120
Nonalcoholic fatty liver disease (NAFLD), ranging from relatively benign simple steatosis to progressive nonalcoholic steatohepatitis (NASH) and fibrosis, is an increasingly common chronic liver disease. Liver biopsy is currently the only reliable to
Publikováno v:
Briefings in Functional Genomics and Proteomics. 7:329-339
Major technological advances have made proteomics an extremely active field for biomarker discovery and validation in recent years. These improvements have lead to an increased emphasis on larger scale, faster and more efficient methods for protein b
Autor:
James R. Ludwig, Dawn P. G. Fitzpatrick, Jinsam You, Mu Wang, Jean-Pierre Wery, Kerry G. Bemis
Publikováno v:
PROTEOMICS – Clinical Applications. 1:246-263
Platinum-based chemotherapy, such as cisplatin, is the primary treatment for ovarian cancer. However, drug resistance has become a major impediment to the successful treatment of ovarian cancer. To date, the molecular mechanisms of resistance to plat
Publikováno v:
Genomics. 84:767-777
Affymetrix's high-density oligonucleotide arrays offer an exciting technology in biomedical research. With more and more statistical involvement in every step of the process, there has been a constant effort to make sure that the expression data are
Publikováno v:
American Journal of PharmacoGenomics. 4:129-139
Introduction: The hybridization intensities derived from microarray experiments, for example Affymetrix’s MAS5 signals, are very often transformed in one way or another before statistical models are fitted. The motivation for performing transformat
Autor:
Hui-Rong Qian, Kerry G. Bemis, Christy Love, Lawrence M. Gelbert, Shuguang Huang, Chad D. Geringer
Publikováno v:
American Journal of PharmacoGenomics. 3:279-290
Oligonucleotide and cDNA microarray experiments are now common practice in biological science research. The goal of these experiments is generally to gain clues about the functions of genes by measuring how their expression levels rise and fall in re
Autor:
Kerry G. Bemis
Publikováno v:
Wiley StatsRef: Statistics Reference Online.
Publikováno v:
Journal of Molecular Biomarkers & Diagnosis.
Over 15,000 women die from ovarian cancer and there are approximately 23,000 new cases diagnosed each year. Platinum-based chemotherapy is still the primary treatment for ovarian cancer. Most patients with the disease are initially responsive to chem